T2 Biosystems (TTOO) Competitors $0.85 -0.03 (-3.41%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TTOO vs. STIM, CTSO, COCH, LUCD, ICAD, ALUR, BLAC, CLGN, APYX, and CODXShould you be buying T2 Biosystems stock or one of its competitors? The main competitors of T2 Biosystems include Neuronetics (STIM), Cytosorbents (CTSO), Envoy Medical (COCH), Lucid Diagnostics (LUCD), iCAD (ICAD), Allurion Technologies (ALUR), Bellevue Life Sciences Acquisition (BLAC), CollPlant Biotechnologies (CLGN), Apyx Medical (APYX), and Co-Diagnostics (CODX). These companies are all part of the "medical equipment" industry. T2 Biosystems vs. Neuronetics Cytosorbents Envoy Medical Lucid Diagnostics iCAD Allurion Technologies Bellevue Life Sciences Acquisition CollPlant Biotechnologies Apyx Medical Co-Diagnostics Neuronetics (NASDAQ:STIM) and T2 Biosystems (NASDAQ:TTOO) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, community ranking, valuation, analyst recommendations, media sentiment, risk, earnings and profitability. Does the media favor STIM or TTOO? In the previous week, Neuronetics had 2 more articles in the media than T2 Biosystems. MarketBeat recorded 2 mentions for Neuronetics and 0 mentions for T2 Biosystems. Neuronetics' average media sentiment score of 0.00 equaled T2 Biosystems'average media sentiment score. Company Overall Sentiment Neuronetics Neutral T2 Biosystems Neutral Which has stronger valuation & earnings, STIM or TTOO? Neuronetics has higher revenue and earnings than T2 Biosystems. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeuronetics$71.35M0.44-$30.19M-$1.12-0.92T2 Biosystems$7.19M2.07-$50.08MN/AN/A Is STIM or TTOO more profitable? Neuronetics has a net margin of -45.06% compared to T2 Biosystems' net margin of -677.58%. T2 Biosystems' return on equity of 0.00% beat Neuronetics' return on equity.Company Net Margins Return on Equity Return on Assets Neuronetics-45.06% -109.00% -31.72% T2 Biosystems -677.58%N/A -155.89% Do analysts prefer STIM or TTOO? Neuronetics presently has a consensus target price of $4.67, suggesting a potential upside of 353.07%. T2 Biosystems has a consensus target price of $5.00, suggesting a potential upside of 487.61%. Given T2 Biosystems' higher possible upside, analysts plainly believe T2 Biosystems is more favorable than Neuronetics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Neuronetics 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75T2 Biosystems 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more risk and volatility, STIM or TTOO? Neuronetics has a beta of 2.21, indicating that its stock price is 121% more volatile than the S&P 500. Comparatively, T2 Biosystems has a beta of 0.38, indicating that its stock price is 62% less volatile than the S&P 500. Does the MarketBeat Community prefer STIM or TTOO? T2 Biosystems received 278 more outperform votes than Neuronetics when rated by MarketBeat users. However, 68.45% of users gave Neuronetics an outperform vote while only 64.44% of users gave T2 Biosystems an outperform vote. CompanyUnderperformOutperformNeuroneticsOutperform Votes12868.45% Underperform Votes5931.55% T2 BiosystemsOutperform Votes40664.44% Underperform Votes22435.56% Do insiders & institutionals have more ownership in STIM or TTOO? 53.6% of Neuronetics shares are held by institutional investors. Comparatively, 23.2% of T2 Biosystems shares are held by institutional investors. 9.8% of Neuronetics shares are held by company insiders. Comparatively, 0.1% of T2 Biosystems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryNeuronetics beats T2 Biosystems on 11 of the 15 factors compared between the two stocks. Ad Crypto 101 MediaCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Click here to reserve your spot at the emergency crypto summit now. Get T2 Biosystems News Delivered to You Automatically Sign up to receive the latest news and ratings for TTOO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TTOO vs. The Competition Export to ExcelMetricT2 BiosystemsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.87M$4.41B$5.40B$8.53BDividend YieldN/A42.37%5.13%4.14%P/E RatioN/A38.74115.5615.18Price / Sales2.0765.071,484.3492.77Price / CashN/A49.1039.6634.07Price / Book-0.124.264.665.02Net Income-$50.08M$11.52M$119.06M$225.46M7 Day Performance-21.21%1.04%0.80%0.37%1 Month Performance-54.74%0.92%5.65%3.57%1 Year Performance-85.53%39.40%36.76%29.44% T2 Biosystems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TTOOT2 Biosystems1.8145 of 5 stars$0.85-3.4%$5.00+487.6%-85.7%$14.87M$7.19M0.00180STIMNeuronetics2.5995 of 5 stars$1.03flat$4.67+353.1%-10.4%$31.22M$71.35M-0.92180News CoverageCTSOCytosorbents1.9 of 5 stars$1.00-1.0%$2.00+100.0%-32.0%$54.43M$36.35M-1.89186Upcoming EarningsAnalyst ForecastNews CoverageCOCHEnvoy Medical3.584 of 5 stars$2.55-3.8%$7.92+210.5%+104.0%$49.98M$302,000.000.0034News CoverageGap UpHigh Trading VolumeLUCDLucid Diagnostics2.203 of 5 stars$0.92-5.0%$3.94+327.8%-29.2%$49.70M$2.43M-0.7570Gap DownICADiCAD0.461 of 5 stars$1.82-2.2%N/A+37.9%$48.30M$17.32M-16.5567Short Interest ↑ALURAllurion Technologies1.8885 of 5 stars$0.71flat$2.88+305.5%-83.9%$45.64M$53.47M-0.81501Gap DownBLACBellevue Life Sciences AcquisitionN/A$11.03-0.2%N/A+5.3%$44.57MN/A0.00N/ACLGNCollPlant Biotechnologies1.9874 of 5 stars$3.74+1.6%$11.00+194.1%-43.5%$42.84M$689,000.00-2.4370APYXApyx Medical4.5083 of 5 stars$1.19+1.7%$5.00+320.2%-49.1%$41.22M$52.35M-1.45270Upcoming EarningsPositive NewsGap UpCODXCo-Diagnostics3.2307 of 5 stars$1.21flat$1.50+24.0%+13.1%$38.61M$9.14M-0.96100Upcoming EarningsShort Interest ↑ Related Companies and Tools Related Companies Neuronetics Competitors Cytosorbents Competitors Envoy Medical Competitors Lucid Diagnostics Competitors iCAD Competitors Allurion Technologies Competitors Bellevue Life Sciences Acquisition Competitors CollPlant Biotechnologies Competitors Apyx Medical Competitors Co-Diagnostics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TTOO) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding T2 Biosystems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share T2 Biosystems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
